Skip to main content
225 results

On the 28th November the joint National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) will publish their long-awaited single guideline on asthma diagnosis, monitoring and management.

This document is a distillation of the new guidance to provide distinct advice on the changes on the diagnosis and management to asthma. It is not intended to be a comprehensive guide of the new guideline, neither does it cover all non-pharmacological treatments or on-going monitoring.

Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers. 

Inhalation is the main route for administration of drugs for conditions such as asthma or chronic obstructive pulmonary disease. The advantage of administering drugs by inhaler is that drugs are delivered directly to the site of action within the airways.

This document outlines a consensus recommendation based on the best available evidence and expert opinion. Its purpose is to provide guidance on a safe approach within the limitations of the evidence and devices currently available.

Respiratory disease and mental health are interlinked in many ways, with respiratory conditions often impacting mental wellbeing and vice versa. NHS England states that people with severe and enduring mental illness are at greater risk of poor physical health and reduced life expect

Corinne Beirne, Advanced Nurse Practitioner and Amanda Roberts, from PCRS’s patient reference group, discuss what constitutes a good asthma review from a patient’s perspective.

2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.

In November 2024 NICE, in collaboration the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN), released guidance NG245.

Childhood asthma is the most common chronic disease in childhood, with a prevalence of 10.2% in 2018. However, there is evidence of over-and under diagnosis in about 30% in mixed populations of adults and children and young people (CYP).

Antibiotics are crucial for managing infectious diseases and preventing complications like pneumonia or sepsis. However, antimicrobial resistance (AMR) poses a growing global health threat, contributing to over 3 million deaths annually.

Join Frances Barrett (Respiratory Nurse Specialist and PCRS Service Development Committee Member) and Darush Attar-Zadeh (Clinical Fellow Pharmacist and PCRS Executive Committee Member) as they dive into the incredibly important topic of Tobacco Dependency.

2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.